Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation (Request for proposal) from Barda - Aspr / Daappo / Barda Dcma. This notice has closed.
- ClosedDays left to respond
- 1827 daysThis buyer usually gives
- 13%Notices this buyer changes
- $86.8MTypical award from this office
What BidCamel found about this buyer
- This office usually gives bidders 1827 days to respond; this notice gives 95 days.
- It changed 13% of its 8 notices after posting, so check for amendments before you submit.
- It has 5 open bids right now. See them all.
- It has made 1 awards in our records, typically $86.8M.
Companies this office paid before
- Contrafect Corporation: 1 award, $86.8M total
These are past winners at this office, not the winner of this exact contract.
Key details
- Solicitation number
- 75A50126R00001_RFP_NPIVS_27
- NAICS code
- 541714 Research and Development in Biotechnology (except
- Size standard for this code
- 1,000 employees
- Set-aside
- Open to all (no set-aside)
- Buying
- Service
- Place
- Washington, DC · District of Columbia bids
- Posted
- Aug 17, 2026
- Last changed
- Oct 26, 2026 (4 versions)
- Contact
- Contact details are on the SAM.gov notice. Open on SAM.gov
Description
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.
Similar open bids
10 days leftNov 30, 2026
Firefox
Def Advanced Research Projects Agcy
Solicitation
10 days leftNov 30, 2026
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Advanced Research Projects Agency for Health (Arpa-h)
Solicitation
11 days leftNov 30, 2026
Future Program: Laguna
Def Advanced Research Projects Agcy
Special Notice
12 days leftDec 2, 2026
Laguna Industry Day
Def Advanced Research Projects Agcy
Special Notice
14 days leftDec 4, 2026
RFI Alzheimer’s Research Program (AZRP) Public
Defense Health Agency
Sources Sought
From SAM.gov and USAspending.gov public data. BidCamel adds the buyer and award facts.